calcal
02-27-2008, 03:25 AM
From AAN looking at variations in MS activity throughout the seasons:
P08.184] Does Disease Activity as Measured by Contrast Enhancing Lesions in Multiple Sclerosis Reflect a Seasonal Variation?
Joan M. Ohayon, Sungyoung Auh, Henry McFarland, Gaithersburg, MD, Fredric Cantor, Bethesda, MD
OBJECTIVE: To determine if there is a seasonal variation in disease activity as measured by contrast-enhancing lesions (CELs) in patients with multiple sclerosis (MS).
BACKGROUND: Studies reporting to detect seasonal variations in MS activity have differing and contradictory conclusions. Some conclude summer to be worse; others conclude winter to be worse. Various causes including sunlight and its relation to vitamin D and viral exposure have been proposed. Most studies evaluated relapses; fewer evaluated MRI changes.
DESIGN/METHODS: Since CELs are thought to represent a marker of acute disease activity, we retrospectively reviewed MRI scans done at approximately monthly intervals from relapsing remitting (n=67), secondary progressive (n=11), and primary progressive (n=2) MS patients followed for at least one year. Three month seasonal data was evaluated in two different paradigms: seasons defined by average daily temperature and seasons defined by amount of sunlight, as determined by the National Oceanic and Atmospheric Administration and the United States Naval Observatory, respectively. Each patients mean number of CELs per season (based on mean CELs per scan) was compared to the yearly mean to determine best and worst seasons for the group. Additionally, a second analysis was performed examining each patients best and worst season.
RESULTS: CELs occurred in 73 patients. Repeated measures of ANOVA showed no significant seasonal effect by temperature: F(3,216)=0.89 with p=0.4447 or by sunlight exposure: F(3,216)=1.15 with p-value=0.3067. Evaluation of best and worst seasons for each patient also showed no seasonal effect. Seven patients had no CELs and, therefore, no seasonal variation.
CONCLUSIONS/RELEVANCE: We found no significant seasonal variation in the mean number of contrast enhancing lesions in seasons defined by temperature or by amount of sunlight. Supported by: The Intramural Program of the National Institutes of Neurological Disorders and Stroke, NIH.
Category - MS and Related Diseases
SubCategory - Clinical Science
P08.184] Does Disease Activity as Measured by Contrast Enhancing Lesions in Multiple Sclerosis Reflect a Seasonal Variation?
Joan M. Ohayon, Sungyoung Auh, Henry McFarland, Gaithersburg, MD, Fredric Cantor, Bethesda, MD
OBJECTIVE: To determine if there is a seasonal variation in disease activity as measured by contrast-enhancing lesions (CELs) in patients with multiple sclerosis (MS).
BACKGROUND: Studies reporting to detect seasonal variations in MS activity have differing and contradictory conclusions. Some conclude summer to be worse; others conclude winter to be worse. Various causes including sunlight and its relation to vitamin D and viral exposure have been proposed. Most studies evaluated relapses; fewer evaluated MRI changes.
DESIGN/METHODS: Since CELs are thought to represent a marker of acute disease activity, we retrospectively reviewed MRI scans done at approximately monthly intervals from relapsing remitting (n=67), secondary progressive (n=11), and primary progressive (n=2) MS patients followed for at least one year. Three month seasonal data was evaluated in two different paradigms: seasons defined by average daily temperature and seasons defined by amount of sunlight, as determined by the National Oceanic and Atmospheric Administration and the United States Naval Observatory, respectively. Each patients mean number of CELs per season (based on mean CELs per scan) was compared to the yearly mean to determine best and worst seasons for the group. Additionally, a second analysis was performed examining each patients best and worst season.
RESULTS: CELs occurred in 73 patients. Repeated measures of ANOVA showed no significant seasonal effect by temperature: F(3,216)=0.89 with p=0.4447 or by sunlight exposure: F(3,216)=1.15 with p-value=0.3067. Evaluation of best and worst seasons for each patient also showed no seasonal effect. Seven patients had no CELs and, therefore, no seasonal variation.
CONCLUSIONS/RELEVANCE: We found no significant seasonal variation in the mean number of contrast enhancing lesions in seasons defined by temperature or by amount of sunlight. Supported by: The Intramural Program of the National Institutes of Neurological Disorders and Stroke, NIH.
Category - MS and Related Diseases
SubCategory - Clinical Science